VTGN Earnings

Quarterly EPS
$-0.42
Q2 2025
$-0.46
Q3 2025
$0.00
Q4 2025
$-0.47
Q1 2026
$-0.54
Q2 2026
$-0.45
Q3 2026
$-0.38
Q4 2026
$-0.30
Q1 2027
Latest Revenue1.5M
Latest Net Income-13030000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q1 2027-$0.301.5M-13030000+504.9%+36.2%
Q4 2026-$0.38465.0K-16274000
Q3 2026-$0.45303.0K-18899000+29.5%+2.2%
Q2 2026-$0.54258.0K-19417000+41.0%-28.6%
Q1 2026-$0.47244.0K-15095000+190.5%-34.3%
Q4 2025
Q3 2025-$0.46234.0K-14089000-43.1%-109.1%
Q2 2025-$0.42183.0K-12961000-34.2%+36.4%
Q1 2025-$0.3584.0K-10733000
Q4 2024-$0.31197.0K-9521000
Q3 2024-$0.22411.0K-6350000
Q2 2024-$0.66278.0K-6588000
Vistagen Therapeutics (VTGN) — Earnings